TrialCancer science2021

Pembrolizumab plus pemetrexed-platinum for metastatic nonsquamous non-small-cell lung cancer: KEYNOTE-189 Japan Study.

Hidehito Horinouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.